MyFinsight
Home
Blog
About
Syringes
$5,299,242
(-10.61%↓ Y/Y)
Blood Collection
Products
$294,940
(-2.59%↓ Y/Y)
Easy Point Needles
$272,174
(-93.51%↓ Y/Y)
Other Products
$7,164
(-62.55%↓ Y/Y)
Syringes
$829,832
(-86.00%↓ Y/Y)
Easy Point Needles
$347,092
(-91.73%↓ Y/Y)
Syringes
$121,478
(-97.95%↓ Y/Y)
Easy Point Needles
$27,152
(-99.35%↓ Y/Y)
Blood Collection
Products
$1,000
(-99.67%↓ Y/Y)
Other Products
$549
(-97.13%↓ Y/Y)
United States Sales
$5,873,520
North And South
America Sales Excluding...
$1,176,924
Other International
Sales
$150,179
Gain on trading debt
and equity...
$6,366,467
Other income - tia
$1,468,734
(-0.17%↓ Y/Y)
Interest and other income
$341,164
(142.78%↑ Y/Y)
Sales, net
$7,200,623
(-31.07%↓ Y/Y)
Net income (loss)
before income taxes
$2,832,611
(3406.92%↑ Y/Y)
Loss from operations
-$5,145,902
(-0.29%↓ Y/Y)
Gross profit (loss)
$190,852
(278.22%↑ Y/Y)
Unrealized gain (loss) on
debt and equity...
-$179,147
(-111.52%↓ Y/Y)
Interest expense
$18,705
(-15.96%↓ Y/Y)
Total cost of sales
$7,009,771
(-33.57%↓ Y/Y)
Net income (loss)
$2,830,774
(3336.24%↑ Y/Y)
Provision for income taxes
$1,837
(1.27%↑ Y/Y)
Total operating
expenses
$5,336,754
(6.23%↑ Y/Y)
Product
$6,351,053
(-34.67%↓ Y/Y)
Royalty
$658,718
(-20.75%↓ Y/Y)
Net income (loss)
applicable to common...
$2,773,163
(2011.45%↑ Y/Y)
Preferred stock dividend
requirements
$57,611
(0.00%↑ Y/Y)
General and
administrative
$3,614,724
(12.89%↑ Y/Y)
Sales and marketing
$1,534,739
(-7.64%↓ Y/Y)
Research and development
$187,291
(17.02%↑ Y/Y)
Back
Back
Income Statement
RETRACTABLE TECHNOLOGIES INC (RVP)
RETRACTABLE TECHNOLOGIES INC (RVP)
source: myfinsight.com